The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate or its related term are showing as below:
LABFF'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -16.8 Med: 4.4 Max: 128.6
Current: -0.7
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Laboratorios Farmaceuticos Rovi was 128.60% per year. The lowest was -16.80% per year. And the median was 4.40% per year.
LABFF's 3-Year Dividend Growth Rate is ranked worse than 73.22% of 351
companies
in the Drug Manufacturers industry
Industry Median: 7.7
vs LABFF: -0.70
During the past 12 months, Laboratorios Farmaceuticos Rovi's average Dividends Per Share Growth Rate was -15.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -0.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 40.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 29.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Laboratorios Farmaceuticos Rovi was 0.52. The lowest was 0.11. And the median was 0.30.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Laboratorios Farmaceuticos Rovi Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.959400
2026-07-13
2026-07-14
2026-07-15
Cash Dividend
annually
EUR:USD 1.169591
EUR 0.935100
2025-07-14
2025-07-15
2025-07-16
Cash Dividend
annually
EUR:USD 1.166861
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Laboratorios Farmaceuticos Rovi's Dividend Yield (%) for Today is calculated as
Current Share Price is $90.61.
Laboratorios Farmaceuticos Rovi's Dividends per Share for the trailing twelve months (TTM) ended in Today is $2.2132373265.
During the past 13 years, the highest Dividend Yield of Laboratorios Farmaceuticos Rovi was 3.28%. The lowest was 0.30%. And the median was 1.10%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laboratorios Farmaceuticos Rovi 3-Year Dividend Growth Rate Related Terms>
LABFF vs ZTS, UTHR, VTRS: 3-Year Dividend Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laboratorios Farmaceuticos Rovi 3-Year Dividend Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of -0.70% mean?
Laboratorios Farmaceuticos Rovi (LABFF) has a 3-Year Dividend Growth Rate of -0.70% as of Mar. 2026. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. According to the industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #257 out of 351 companies in the Drug Manufacturers industry, placing it in the top 73.2%.
Is Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate too high?
Laboratorios Farmaceuticos Rovi's current 3-Year Dividend Growth Rate is -0.70%. Based on the distribution chart, Laboratorios Farmaceuticos Rovi ranks #257 out of 351 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Laboratorios Farmaceuticos Rovi has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Laboratorios Farmaceuticos Rovi's 3-Year Dividend Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Laboratorios Farmaceuticos Rovi ranks #257 out of 351 companies for 3-Year Dividend Growth Rate. This places Laboratorios Farmaceuticos Rovi in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 7.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Drug Manufacturers company?
The median 3-Year Dividend Growth Rate among Drug Manufacturers companies is 7.70, based on 351 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Laboratorios Farmaceuticos Rovi and its competitors. For the Drug Manufacturers industry, the median 3-Year Dividend Growth Rate is 7.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laboratorios Farmaceuticos Rovi's current 3-Year Dividend Growth Rate is -0.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laboratorios Farmaceuticos Rovi stock overvalued right now?
Laboratorios Farmaceuticos Rovi (LABFF) has a current 3-Year Dividend Growth Rate of -0.70%. The stock's GF Value™ is $82.58, compared to a current price of $90.61 — trading 9.7% above its estimated fair value. The current 3-Year Dividend Growth Rate is -0.70%. Laboratorios Farmaceuticos Rovi's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Laboratorios Farmaceuticos Rovi (LABFF), the current 3-Year Dividend Growth Rate is -0.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Laboratorios Farmaceuticos Rovi (LABFF) Overvalued in 2026?
Based on GuruFocus' analysis, Laboratorios Farmaceuticos Rovi stock appears to be overvalued.
The current stock price of $90.61 is trading 9.7% above its estimated GF Value™ of $82.58.
Key valuation signals for LABFF:
3-Year Dividend Growth Rate: -0.70%
GF Value™: $82.58 vs. price of $90.61 (9.7% above fair value)
No single metric tells the full story. See the LABFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Laboratorios Farmaceuticos Rovi Business Description
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.
93GF Score
Get the complete analysis for LABFF
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LABFF has been successfully added to your 